Following the acquisition of three office park assets in Phoenix and Portland in the US on Nov 30, analysts are positive on Manulife US REIT’s (MUST) prospects.
CGS-CIMB Research analysts Lock Mun Yee and Eing Kar Mei have kept “add” on MUST with an unchanged target price of 91.8 US cents ($1.26).
In their report on Nov 30, Lock and Eing see the acquisition as boosting the REIT’s exposure to growth sectors such as tech and healthcare as well as growth markets such as Atlanta, Phoenix and Portland.
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
